Sensex up, pharma shares down on Donald Trump’s outburst

by B2B Desk 2017-01-12 08:38:40

Indian shares edged up on Thursday, led by IT stocks on hopes US President-elect Donald Trump may not proceed with stringent visa rules. Gains were, however, limited as pharma stocks fell on Trump’s comment that drug makers were “getting away with murder” in what they charge the government for medicines, and promised that would change. However, he did not make any announcements on potentially tougher visa rules for software services exporters, a concern for the sector ever since his election.

Share

nilkamal

POPULAR POSTS

Flipkart sweetens buyout offer for Snapdeal with $950 million offer

by B2B Desk, 2017-07-18 10:17:35

BPCL Makes Its First US Oil Purchase, Buys Mars, Poseidon

by B2B Desk, 2017-07-17 09:08:49

Mahindra & Mahindra heads to US; manufacturing unit to start operations soon

by B2B Desk, 2017-07-17 09:09:02

Paytm buys majority stake in ticketing platform Insider.in

by B2B Desk, 2017-07-14 07:22:52

Flipkart may make revised offer of $950 million for Snapdeal

by B2B Desk, 2017-07-13 09:12:42

Two airlines may start ops under low-cost scheme by Sept end

by B2B Desk, 2017-07-13 09:12:28

Jaitley's 10% tax on income from carbon credits a mixed bag

by B2B Desk, 2017-07-12 11:12:52

Follow on Insta

RECENTLY PUBLISHED

Loan EMIs to Drop as RBI Slashes Repo Rate - Full MPC December 2025 Highlights

by Shan, 2025-12-05 11:49:44

Pine Labs IPO 2025: Listing Date, Grey Market Premium, and Expert Outlook

by Shan, 2025-11-05 09:57:07

The Agentic Revolution: Why Salesforce Is Betting Its Future on AI Agents

by Shan, 2025-11-05 10:29:23

Top 10 Insurance Companies in India 2026: Life, Health, and General Insurance Leaders Explained

by Shan, 2025-10-30 10:06:42

OpenAI Offers ChatGPT Go Free in India: What’s Behind This Big AI Giveaway?

by Shan, 2025-10-28 12:19:11

Best Silver Investment Platforms for 2025: From CFDs to Digital Vaults Explained

by Shan, 2025-10-23 12:22:46

x